Heparin-binding growth factors present in pig uterine tissue were purified by approx. 50000-fold using a combination of ammonium sulphate precipitation, ion-exchange chromatography and heparin-affinity chromatography. Purification of the uterus-derived growth factors (UDGFs) was monitored by the stimulation of [3H]thymidine incorporation into Swiss 3T3 cells and by a radioreceptor assay using 1251_ labelled epidermal growth factor (EGF) as the ligand. The latter was shown to be a novel, rapid and reliable assay for heparin-binding growth factors which utilizes their trans-modulation of EGF receptor affinity.
INTRODUCTION
There is considerable interest in embryo-maternal interactions during early pregnancy. Pigs have been used extensively in these studies because substantial quantities of both embryonic and uterine material can be recovered for experimental use. During the pre-implantation period in this species, there is a striking change in blastocyst -morphology and a high incidence of embryonic mortality (Perry & Rowlands, 1962) . Although the underlying causes of these events are poorly understood, it is clear that development and survival of the early pig embryo is influenced by its local environment in early pregnancy (see Roberts & Bazer, 1988) .
It has been reported that uterine luminal fluid from pigs or sheep contains compounds which stimulate cellular DNA synthesis (Flint, 1981; Ikeda & Sirbasku, 1984; Simmen et al., 1988; Bird et al., 1988) , and that endometrial explants enhance the rate ofprotein synthesis in blastocyst co-cultures (Rice et al., 1981) . Although these observations suggest that uterus-derived factors may influence survival and development of the preimplantation pig embryo, the nature of the compounds involved is unknown. Since polypeptide growth factors are possible candidates, we have investigated their presence in uterine tissue. We have reported previously that an anionic polypeptide growth factor, which stimulates DNA synthesis in Swiss mouse 3T3 cell cultures, is present in pig uterine extracts (Brigstock et al., 1986) . We now report that the principal Swiss 3T3 cell-growthpromoting factors in the pig uterus bind strongly to heparin and are closely related to the acidic and basic forms of fibroblast growth factor (FGF) (Lobb & Fett, 1984; Gospodarowicz et al., 1984) . In addition, we have found that heparin-binding growth factors (HBGFs) have the ability to trans-modulate (Brown et al., , 1984 Collins et al., 1983 ) the affinity of the receptor for epidermal growth factor (EGF) on Swiss 3T3 cells. This finding has allowed us to detect HBGFs by a radioreceptor assay using 125I-labelled EGF as the ligand, and has provided a simple and rapid method of monitoring HBGF purification. EXPERIMENTAL Animals and materials [methyl-3H] Thymidine, Na125I and recombinant basic FGF (bFGF) were from Amersham International scribed . Antisera against synthetic peptides of bovine acidic FGF (aFGF) and bFGF were provided by Andrew Baird (Salk Institute, San Diego, CA, U.S.A.). Recombinant human a-endothelial cell growth factor (aECGF) and antiserum to aECGF were provided by Michael Jaye (Rorer Biotechnology, Springfield, VA, U.S.A.). [ocECGF is a truncated form of aFGF lacking the first six N-terminal residues (Burgess et al., 1986) .] Culture medium, trypsin, antibiotics and newborn calf serum were from Flow Laboratories (Irvine, Scotland, U.K.).
Reproductive tracts were removed from gilts (17-19 days pregnant) about 20 min after stunning and exsanguination at a local slaughterhouse. The tracts were transported on ice to the laboratory within 10 min. Uteri were dissected free of ovaries, mesometrium and cervix, and then flushed with 20 ml of Dulbecco's modified Eagle's medium (DMEM) to remove embryonic material. Each uterine horn was cut into 2 cm pieces which were stored at -20°C until processed. Cell culture Stock cultures of Swiss mouse 3T3 cells were maintained and passaged as described previously . For experimental use, cells were seeded in 24-well cluster plates (Nunc) at a density of 1.25 x 104 cells/well in 0.5 ml of DMEM containing 10 % (v/v) newborn calf serum.
The protein content of uterine samples was determined by the method of Bradford (1976) using porcine gammaglobulin as standard. For samples below the sensitivity of this assay, protein content was estimated by comparison with standard proteins on silver-stained SDS/polyacrylamide gels.
DNA synthesis assay and EGF binding assays Cells were used 6-7 days after seeding, when they had formed a confluent, quiescent monolayer. [methyl-3H] Thymidine (1 ,uCi/ml) and aliquots of test samples [up to 10 % (v/v) ] were added to the depleted medium in each well and the cells were incubated for 40 h at 37°C. The medium was removed from the wells and the cells were washed twice with 1-2 ml of cold (4°C) phosphatebuffered saline (PBS, 138 mM-NaCl/2.8 mM-KCl/ 8.0 mM-Na2HPO4/ 1.45 mM-KH2PO4/0.9 1 mM-CaCl2/ 0.49 mM-MgCl2, pH 7.2). The cells were extracted for 30 min with 1-2 ml of cold 5 % (w/v) trichloroacetic acid, rinsed with ethanol, air dried and dissolved in 0.5 ml of 0.1 M-NaOH which was transferred to 10 ml of acidified scintillation fluid for counting of 3H radioactivity.
For measurement of 125I-EGF binding, cell monolayers were rinsed with binding medium (DMEM containing 1 mg of BSA/ml, 0.1 ,IM-KI and 50 mM-Bes, adjusted to pH 7.0). Each well then received 0.5 ml of binding medium containing 1251-EGF (1 ng/ml) and up to 100% (v/v) of test sample. After incubation at 37°C for 60 min, the cells were washed three times with cold PBS containing 1 mg of BSA/ml and 0.1 M-KI. The cells were solubilized in 1 ml of 0.5 M-NaOH, and cell-associated 1251-EGF was measured using a gamma counter.
Purification and characterization of UDGFs
Tissue extraction, ammonium sulphate precipitation and ion-exchange chromatography. All procedures were carried out at 4 'C. Frozen uteri were thawed rapidly and approx. 200 g of tissue was homogenized in 400 ml of cold 0.15 M-ammonium sulphate solution in a Waring blender at high speed for 1 min. The homogenate from approx. 1 kg of uterus was pooled, blended again at high speed for 1 min and centrifuged at 5000 g for 30 min. The supernatant was filtered through glass wool and adjusted to pH 4.5 with 5 M-HCI. The acidified solution was stirred for 2 h and then centrifuged at 5000 g for 30 min. Ammonium sulphate precipitation and CM-Sephadex C-50 chromatography were performed as described by Gospodarowicz et al. (1984) .
Heparin-agarose affinity chromatography. Biologically active fractions from the CM-Sephadex column were pooled and applied directly to a heparin-agarose (Sigma) column (1.6 cm x 1Icm) which had been equilibrated with 20 mM-Tris/HCl (pH 8.0) containing 0.5 M-NaCl. Typically, the CM-Sephadex eluate from about 0.5 kg of starting material was applied to the heparin-agarose column in a single run. The column was then washed with 100 ml of equilibration buffer before elution by a 0.5-2 M-NaCl gradient in 20 mM-Tris/HCI (pH 8.0) . A GP250 Gradient Programmer (Pharmacia) was used to generate the salt gradient and to maintain a pumped flow rate of 0.5 ml/min. Conductivity of the column output was monitored using a conductivity cell (adapted to flowthough use) linked to a conductivity meter. Absorbance (280 nm) was monitored using a u.v. column monitor (LKB 2238 Uvicord SII). Fractions (10 ml) were collected over the entire gradient and tested for biological activity.
In order to characterize heparin-purified UDGFs by h.p.l.c. or SDS/PAGE, it was necessary to concentrate and desalt the samples. This was achieved by passing individual fractions through small columns (4 mm x 1O mm) of Vydac C4 bonded-silica particles (15-20,m) . Columns were first washed with 1 ml of 20 % acetonitrile/0.1 % trifluoroacetic acid and retained proteins were then eluted in 1 ml of 80 % acetonitrile/ 0.1 % trifluoroacetic acid. This eluate was dried in a Speed-Vac concentrator (Savant) and reconstituted in either 20 % acetonitrile/0.1I% trichloroacetic acid (for h.p.l.c.) or complete sample buffer (for SDS/PAGE). Immunoblotting. Heparin-purified UDGF samples were blotted from gels on to nitrocellulose sheets by electrotransfer (Towbin et al., 1979) primary antiserum. Immunoreactive proteins were revealed by successive incubations with biotinylated goat anti-rabbit IgG, a pre-formed streptavidin-biotinhorseradish peroxidase complex (both from Amersham International) and diaminobenzidine.
Amino acid composition and sequencing. Amino acid compositions were determined using an LKB 4151 Alpha Plus analyser. N-Terminal sequencing was performed using an Applied Biosystems 470A gas phase sequenator. Phenylthiohydantoin (PTH) derivatives were identified using a 120A on-line PTH analyser.
RESULTS
We have observed previously that extracts of pig uterus contain mitogenic activity for Swiss 3T3 cells (Brigstock et al., 1986) . Vascular horn at autopsy with approx. 500 ml of 0.9 % (w/v) NaCl before dissection failed to remove biological activity, indicating that the factor(s) responsible was probably not derived directly from blood. Preliminary characterization (results not shown) indicated that the uterine growth factor(s) had several similarities with the FGFs. Since FGFs have been purified by a combination of ion-exchange chromatography and affinity chromatography on heparin-Sepharose (Lobb & Fett, 1984; Lobb et al., 1986) , we have adopted this procedure for the purification of the uterine factors. CM-Sephadex C-50 and heparin-agarose chromatography
When the redissolved and dialysed ammonium sulphate precipitate was loaded on to the CM-Sephadex C-50 column, most of the protein passed unretarded through the column and contained only low levels of biological activity (Fig. 1) . A major peak of protein was eluted by buffer containing 0.2 M-NaCl, but this peak contained only low levels of cell-growth-promoting activity. However, a large peak of growth factor activity was eluted from the column by buffer containing 0.65 MNaCl (Fig. 1) . Material which inhibited the binding of '25I-EGF to the cells was found to co-elute with the mitogenic activity (Fig. 1) .
Most (90 %) of the protein in the active fractions from the CM-Sephadex column was either unretarded by the heparin-agarose column or was eluted as a major protein peak when the column was washed with 20 mM-Tris/HCl (pH 8.0) containing 0.5 M-NaCl. An additional small protein peak was eluted at the beginning of the 0.5-2 MNaCl gradient. Thereafter the absorbance of the column output remained below the detection limit of the column monitor (Fig. 2) . When the fractions eluted by the salt gradient were assayed, two major peaks of 3T3 cellstimulating activity were found; one (named azUDGF) was eluted at approx. 1.3 M-NaCl and the other (named /JUDGF) was eluted between 1.5 M-and 1.8 M-NaC1 (Fig. 2) . Both a-and fl-UDGF stimulated DNA synthesis in 3T3 cells and inhibited 125I-EGF binding to these cells. The dose-response curves for these effects at different stages of purification are shown in Fig. 3 and summarized in Table 1 . Characterization of heparin-and h.p.l.c.-purified UDGFs SDS/PAGE and reversed-phase h.p.l.c. When heparinpurified ,/UDGF was subjected to SDS/PAGE, a prominent doublet which migrated at 17.7 kDa and 17.2 kDa was observed after silver staining (Fig. 4a ). When heparin-purified /?UDGF was purified further by reversed-phase h.p.l.c., the elution profile of biologically active material correlated with the elution profile of this protein doublet (Figs. 4b and 4c ). SDS/PAGE and silver staining of heparin-purified ZUDGF showed that this material contained numerous proteins, and it was not possible to correlate biological activity with the elution of a particular protein(s) after C4 h.p.l.c. (results not shown).
Immunoblotting. The 17.2/17.7 kDa protein doublet observed in heparin-purified /?UDGF preparations by silver staining (Fig. 4a) was detected on immunoblots probed using an antiserum to bFGF-(106-120) but not by an antiserum to aFGF-(1-15) (Fig. Sa) . The levels of this immuno-stained doublet were maximal in fractions 18-20, which possessed maximal biological activity (see Fig. 2 ), although lower levels of the doublet were detected in earlier fractions (Fig. Sa) 
. 110 antisera failed to stain the proteins (Fig. 5b, lanes 4 and  5) . Although the upper (17.7 kDa) band of the doublet was stained with an antiserum against bFGF-(1-10), the lower (17.2 kDa) band was not detected using this antiserum (Fig. 5b, lane 6) , suggesting that it may be an N-terminally truncated variant of the 17.7 kDa band.
When blots of individual fractions from heparinagarose columns were probed using an antiserum raised against aFGF-(1-15), proteins at 21 and 16.5 kDa were stained (Fig. 5a, lower blot) . The 21 kDa protein was not correlated with elution of aUDGF activity, since it was apparently present at similar levels in all fractions. However, the 16.5 kDa protein was detected only in fractions 14-15, which were shown to possess aUDGF mitogenic activity (see Fig. 2 ). Because the staining of the 16.5 kDa protein was rather faint, blots of the aUDGFcontaining fractions from a heparin-agarose column were also probed with an antiserum raised against aECGF which corresponds to aFGF-(7-140) (Burgess et al., 1986) . The 16.5 kDa protein reacted strongly with this antiserum (Fig. Sc, lanes 2 and 3) . Furthermore, the immuno-stained band was found to co-migrate on SDS/PAGE with recombinant aECGF (Fig. Sc, lane 7) . In contrast, the 16.5 kDa protein was not detected using non-immune serum (Fig. 5c, lane 6) or an antiserum to bFGF-(73-87) (Fig. Sc, lane 5) . The latter antiserum caused light staining of protein(s) of a slightly higher molecular mass (17-18 kDa) as would be expected from the known presence of the flUDGF doublet in these fractions (see Fig. Sa) .
In addition to the 17.2/17.7 kDa protein doublet, several other bFGF-immunoreactive proteins were detected in fractions from the heparin column (Fig. Sa) . Two proteins (14 kDa and 32 kDa) were detected in fractions 18-20, and a third immunoreactive protein (27 kDa) was eluted earlier in fractions 12-14 at a NaCl concentration of 0.9-1.1 M. The 14 kDa protein was always weakly stained and is possibly a breakdown product from the /JUDGF doublet. The 32 kDa band may be due to dimerization of doublet proteins, since an immuno-stained band at this position was also observed in lanes loaded with high concentrations (100 ng) of purified recombinant bFGF (results not shown). In addition, the 32 kDa band was not detected by an antiserum raised against the peptide bFGF-(-8 to + 1), corresponding to the nine additional residues recently identified in an N-terminally extended form of bFGF . In contrast, the 27 kDa protein in fractions 12-14 reacted as strongly with this antiserum as with anti-bFGF-(106-120) (results not shown). The possibility that this band is due to a high-molecular-mass bFGF-related protein merits further study.
Inhibition of '25l-EGF binding by UDGFs and recombinant FGFs. Several peptide and polypeptide mitogens, as well as tumour-promoting phorbol esters, are known to cause a temperature-dependent reduction in the affinity of the EGF receptor (Brown et al., 1984; Schlessinger, 1986) . This effect, which has been termed trans-modulation, is caused by phosphorylation of the EGF receptor at Thrf654 by protein kinase C, although additional mechanisms cannot be excluded (Lin et al., 1986; Davis & Czech, 1986 Walker & Burgess, 1988 (Fig. Sb, lane 1) , bFGF-(73-87) (Fig. Sb, lane 2) and bFGF-(139-146) (Fig. Sb, lane 3) . In contrast, control (Fig. 6a, inset) . Inset: cells were incubated in binding medium containing 1251-EGF (1 ng/ml) and aZUDGF (60 1I/ml) or 8JUDGF (60,u1/ml) or unlabelled EGF (8 ng/ml) for 60 min at either 37°C (El) or 4°C (El). The cultures were washed and cell-associated radioactivity was determined. Each value is the mean of three determinations of 125I-EGF binding to separate dishes of cells.
The estimated protein concentrations of the a-and ,J-UDGF pools were 1.2 and 0.2 ,ug/ml respectively. (b) Cells were incubated in binding medium containing 1251I-EGF (1 ng/ml) and either aFGF (-, 0) or bFGF (U, El) for 60 min at either 37°C (0, 80% (Fig. 6b) . In contrast, neither factor caused substantial inhibition of binding when the assay was performed at 4°C (Fig. 6b) . A Scatchard plot very similar to that presented in Fig. 6(a) fractions from each heparin-agarose run were pooled (total vol. 500 ml) and pumped directly on to a Vydac C4 reversed-phase column in the presence of 5 % acetonitrile and 0.1 0% trifluoroacetic acid. During sample application Amino acid analysis of pIUDGF. Heparin-purified /3UDGF, prepared from 11.5 kg of uterine tissue, was further purified by C4 reversed-phase h.p.l.c. The /JUDGF doublet was eluted from the C4 column at 48 0 acetonitrile and was homogeneous when analysed by silver-stained SDS/PAGE (Fig. 7) . Since attempts to the flow rate was 2 ml/min; thereafter, it was reduced to 0.8 ml/min. The column was washed with 5 % acetonitrile containing 0.1 % trifluoroacetic acid until the absorbance (214 nm) of the column eluate reached baseline levels, and was then eluted with a linear acetonitrile gradient of 0.66 00/min (broken line). Fractions of 800,ul were collected and an aliquot (10/lO) of each fraction was dried, redissolved in complete sample buffer and subjected to SDS/PAGE and silver staining to determine which fractions contained the /UDGF doublet. Fractions 13-15 were pooled, reduced in volume, and used for determination of amino acid composition and sequence. Table 2 . Amino acid composition of pUDGF
The amino acid composition of bovine basic FGF-(1-146) was deduced from sequence analysis (Esch et al., 1985) . Values for amino acid composition of flUDGF were obtained from a 24 h hydrolysis in 6 M-HCI at 1 10°C and calculated assuming a molecular mass of 17.5 kDa. n.d., not determined.
Amino
Pituitary bovine acid were not successful, the amino acid composition of the protein doublet was determined. The composition was very similar to that of the 146-amino-acid form of bFGF, except that the levels of serine and tyrosine were significantly lower in the /?UDGF molecule (Table 2 ). This apparent difference is probably due to the partial destruction of these amino acids by acid hydrolysis during analysis (see Glazer et al., 1985) .
When approx. 450 pmol of the h.p.l.c.-purified /?UDGF was subjected to microsequence analysis, up to four PTH-amino acids were identified in each cycle of degradation, indicating that four peptides were being sequenced simultaneously. When the results from the first 19 cycles were analysed, it became apparent that the data were well fitted to a model of four microheterogeneous forms of bFGF whose N-terminal residues were positions, 1, 3, 7 and 11 of bFGF-(1-146). These four sequences were aligned to give a consensus sequence for ,8UDGF of: Pro-Xaa-Leu-Pro-Glu-Asp-Xaa-Gly-SerGly-Ala-Phe-Pro-Pro-Gly-His-Phe-Lys-Asp-Pro-LysArg-Leu-Tyr. Further details supporting this sequence are available on request from the authors. Although we were unable to unequivocally identify the residues at positions 2 and 7, the remaining 22 residues are identical to the sequence of bovine bFGF (Esch et al., 1985) . This result, together with the amino acid composition and the immunoblotting data, indicate that /JUDGF is porcine bFGF.
DISCUSSION
bFGF has been isolated from several tissues, principally of human or bovine origin Gospodarowicz et al., 1987) . The identification of ,/UDGF as porcine bFGF demonstrates that this angiogenic mitogen is also present in uterine tissues. The high degree of similarity between porcine and bovine bFGF supports previous evidence that bFGF has been very well conserved during evolution. The sequences of human and rat bFGF (predicted from cDNA clones) differ from bovine bFGF by only two and four residues respectively when the 146-amino-acid forms are compared (Abraham et al., 1986; Shimasaki et al., 1988; Kurokawa et al., 1988) . Although h.p.l.c.-purified /JUDGF was microheterogeneous due to N-terminal cleavages, it is not known whether multiple forms are present in the uterus or were generated during purification. Microheterogeneity of bovine bFGF was originally described by Baird and co-workers who isolated an N-terminally truncated [des-(l-15-)bFGF] form of bFGF from corpus luteum, kidney and adrenal gland . In addition, Klagsbrun et al. (1987) have reported cleavage of human bFGF between amino acid residues 11 and 12. Extraction of tissues at neutral pH or in the presence of proteinase inhibitors has been reported to prevent acid-activated proteolytic cleavage of bFGF (Mormede et al., 1985; Klagsbrun et al., 1987) . However, we were unsuccessful in preventing the formation of the 17.2 kDa fiUDGF protein band using these conditions (results not shown). Although four polypeptide chains were detected during sequencing, we observed only two flUDGF bands on silver-or immuno-stained SDS gels of h.p.l.c.-purified samples. It seems probable that either the gels did not fully resolve the microheterogeneous forms of flUDGF present, or that two of the truncated polypeptides were formed during storage of the h.p.l.c.-purified sample before sequencing.
Although bFGF appears to be relatively widely distributed in animal tissues, it was originally thought that anionic HBGFs were present only in brain and retina (Gospodarowicz et al., 1987) . However, this appears not to be the case, since aFGF has now been purified from bovine kidney and its identity confirmed by sequencing (Gautschi-Sova et al., 1987) . Furthermore, aFGF-like factors have been reported to be present in human prostate (Crabb et al., 1986) and in bovine bone (Hauschka et al., 1986) . Unfortunately, we have been unable to obtain amino acid sequence data for aLUDGF, the second heparin-binding mitogen identified in porcine uterus. Nevertheless, its properties (affinity for heparin, immunological cross-reactivity) suggest that it is related to aFGF. However, in the absence of sequence data, this evidence must be interpreted with caution since genes encoding at least four additional (putative) HBGFs have recently been cloned, and the family of known HBGFs seems likely to expand (Yoshida et al., 1987; Delli-Bovi et al., 1988; Zhan et al., 1988; Rubin et al., 1989) .
There is currently considerable interest in the possible existence of high-molecular-mass forms of bFGF. NTerminal extensions of 8, 11 and 16 amino acids have been characterized Sommer et al., 1987; Klagsbrun et al., 1987) and heparin-binding bFGF-immunoreactive proteins of 25 kDa and 22 kDa (Presta et al., 1988) have been reported. Our results suggest the presence, in uterine tissue, of a 27 kDa bFGF-related protein which is eluted from heparin-agarose by approx. 1 M-NaCl and reacts with several antisera raised against bFGF-peptides, including bFGF-(-8 to + 1). We do not know whether 1990
the 27 kDa protein has mitogenic activity, although the fractions from heparin-agarose columns which contain this protein did not stimulate DNA synthesis when tested on Swiss 3T3 cells at 2 % (v/v) . Factors that trans-modulate EGF receptor affinity commonly stimulate phosphoinositide hydrolysis and cause activation of protein kinase C leading to phosphorylation of the receptor. However, some reports have indicated that both protein kinase C-dependent and -independent pathways may be involved in the regulation of EGF receptor affinity by platelet-derived growth factor (Davis & Czech, 1987; Olashaw & Pledger, 1987; Friedman & Rosner, 1987) . The mechanism by which HBGFs alter EGF receptor affinity remains to be defined. Whatever the mechanism involved, the effect on EGF receptor affinity has allowed us to develop a heterologous radioreceptor assay using 125I-EGF as a radioligand. This assay is advantageous because it enables very rapid screening of column fractions for biological activity.
Mitogenic activity has been reported to be present in uterine tissue extracts or uterine fluids from several species (Brigstock et al., 1989) . Ikeda & Sirbasku (1984) isolated a growth factor from sheep uteri which stimulated DNA synthesis in several tumour cell lines. Recent microsequencing studies on similar material purified from pig uteri have demonstrated that the activity is due to two N-terminally truncated forms of insulin-like growth factor I (IGF-I) which possess potent biological activity (Ogasawara et al., 1989) . In addition, low levels of mRNAs for IGF-I (Murphy & Friesen, 1988) and EGF (DiAugustine et al., 1988) have been identified in rat uteri, and high levels of colonystimulating factor I are produced by mouse endometrial cells, apparently under the control of sex steroids (Pollard et al., 1987) . To our knowledge, the presence of FGFs in uterine tissues has not been demonstrated previously. However, it has been known for many years that uterine tissues display angiogenic activity when implanted in the anterior chamber of the eye or on chick chorioallantoic membranes (Markee, 1940; Abel, 1985; Fuchs et al., 1985) . Since both acidic and basic FGFs are potent angiogenic factors (see Folkman & Klagsbrun, 1987) , it is possible that the angiogenesis observed was related to the presence of FGF in the tissue. However, in addition to angiogenic activity, FGFs affect the growth and differentiation of various cell types (see Gospodarowicz et al., 1987) as well as inducing mesoderm formation in early embryos (Slack et al., 1987; Kimelman et al., 1988) . Furthermore, bFGF has been reported to regulate steroid hormone metabolism in ovarian granulosa cells (Baird & Hsueh, 1986) . Taken together, these results suggest that
